Skip to main content
Erschienen in: Wiener klinische Wochenschrift 19-20/2012

01.10.2012 | case report

Failure of pentagastrin-stimulated calcitonin testing in early manifestation of familial medullary thyroid cancer

verfasst von: Prof. Christian Pirich, M.D., Gundula Rendl, M.D., Cornelia Hauser-Kronberger, M.D., Ph.D., Ingrid Häusler, M.D.

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 19-20/2012

Einloggen, um Zugang zu erhalten

Summary

This case report describes three generations of a family with familial medullary thyroid cancer (RET gene mutation L790F). One of the three siblings—all of them carrier of the respective mutation—exhibited the absence of pathological basal and pentagastrin-stimulated calcitonin levels in spite of multifocal medullary thyroid microcancer. This case illustrates the challenge to consider the biological diversity of RET gene mutations in the clinical management of affected gene carriers.
Literatur
1.
Zurück zum Zitat Elisei R, Romei C, Renzini G, Bottici V, Cosci B, Molinaro E, et al. The Timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center. J Clin Endocrinol Metab. 2012;97:426–435. Elisei R, Romei C, Renzini G, Bottici V, Cosci B, Molinaro E, et al. The Timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center. J Clin Endocrinol Metab. 2012;97:426–435.
2.
Zurück zum Zitat Frank-Raue K, Machens A, Scheuba C, et al. Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791. Clin Endocrinol. 2008;69:259–263. Frank-Raue K, Machens A, Scheuba C, et al. Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791. Clin Endocrinol. 2008;69:259–263.
3.
Zurück zum Zitat Saller B, Görges R, Reinhardt W, Haupt K, Janssen OE, Mann K. Sensitive calcitonin measurement by two-site immunometric assays: implications for calcitonin screening in nodular thyroid disease. Clin Lab. 2002;48:191–200. Saller B, Görges R, Reinhardt W, Haupt K, Janssen OE, Mann K. Sensitive calcitonin measurement by two-site immunometric assays: implications for calcitonin screening in nodular thyroid disease. Clin Lab. 2002;48:191–200.
Metadaten
Titel
Failure of pentagastrin-stimulated calcitonin testing in early manifestation of familial medullary thyroid cancer
verfasst von
Prof. Christian Pirich, M.D.
Gundula Rendl, M.D.
Cornelia Hauser-Kronberger, M.D., Ph.D.
Ingrid Häusler, M.D.
Publikationsdatum
01.10.2012
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 19-20/2012
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-012-0241-y

Weitere Artikel der Ausgabe 19-20/2012

Wiener klinische Wochenschrift 19-20/2012 Zur Ausgabe

mitteilungen der gesellschaft der ärzte in wien

Veranstaltungen

MUW resarcher of the month

Researcher of the month, Oktober 2012